KRAS and metastatic neoplasm: In this same study, discordant mutations in KRAS/NRAS and BRAF were not observed; the only private mutations, defined as mutations seen only in the primary or metastatic tumor, were seen at the level of the APC, PIK3CA, SMAD4 and TP53 genes.